Group 1 - Tencent Holdings repurchased 1.036 million shares on November 27 [1] - The total expenditure for the share buyback was approximately HKD 635.7 million [1]

Core Viewpoint - Tencent Holdings announced a share buyback plan, indicating confidence in its stock value and commitment to returning capital to shareholders [1] Group 1 - The company will spend HKD 636 million to repurchase 1.036 million shares [1] - The buyback price range is set between HKD 609 and HKD 620 per share [1]

Core Viewpoint - Tencent Holdings (00700) announced a share buyback plan, committing HKD 636 million to repurchase 1.036 million shares on November 27, 2025 [1] Group 1 - The total amount allocated for the share buyback is HKD 636 million [1] - The number of shares to be repurchased is 1.036 million [1] - The buyback is scheduled for November 27, 2025 [1]

如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00700 | 說明 | | | | | | | 多櫃檯證券代號 | 80700 | RMB 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總 ...

Core Insights - Fangzhou Inc. and Tencent Healthcare have launched an "AI+Chronic Disease Management" solution, enhancing the integration of AI in China's healthcare sector [1][4][7] - The solution leverages Fangzhou's AI+H2H ecosystem and Tencent Cloud's technological capabilities, aiming to improve chronic disease management efficiency [2][6] - The partnership aligns with national health guidelines and supports the "Healthy China 2030" initiative, promoting digital transformation in healthcare [7] Company Overview - Fangzhou Inc. is a leading online chronic disease management platform in China, with 52.8 million registered users and 229,000 physicians as of June 30, 2025 [9] - The company specializes in AI-enabled precision medicine solutions and tailored medical care [9] Technological Framework - The solution is built on a robust technological foundation, utilizing Tencent Healthcare's TI platform for model training, evaluation, and deployment [6] - Tencent's vector database enhances the accuracy of medical knowledge retrieval, supporting the AI's factual outputs [6] Safety and Compliance - Fangzhou has implemented multiple safety measures to mitigate AI hallucinations in clinical settings, including reinforcement learning and rule-based supervision [5][6] - Compliance with regulatory standards for clinical AI is ensured through Tencent Healthcare's AI security measures [6]

Core Viewpoint - Tencent Holdings has been actively repurchasing its shares, with a total of 1.29 billion shares repurchased this year, amounting to HKD 654.15 billion, indicating a strong commitment to shareholder value amidst recent stock price fluctuations [1][2][3][4] Summary by Relevant Sections Share Buyback Activity - On November 26, Tencent repurchased 1.022 million shares at a price range of HKD 618.500 to HKD 629.000, totaling HKD 63.56595 million [1] - Since November 18, the company has conducted buybacks for seven consecutive days, acquiring a total of 7.157 million shares for HKD 4.450 billion [1] - The stock price has decreased by 2.67% during this buyback period [1] Year-to-Date Buyback Statistics - Year-to-date, Tencent has executed 107 buybacks, acquiring 1.29 billion shares for a total expenditure of HKD 654.15 billion [1] - The stock's closing price on the day of the latest buyback was HKD 619.500, reflecting a decline of 0.88% for that day [1] Historical Buyback Prices - The highest buyback price recorded in the recent buyback activities was HKD 640.500 on November 18, while the lowest was HKD 606.500 on November 21 [1] - The buyback prices have shown a range of fluctuations, with the highest price in the last few months reaching HKD 683.000 on October 2 [1][2][3][4]

Core Points - Tencent Holdings (00700) announced a share buyback of 636 million HKD to repurchase 1.022 million shares at a price range of 618.5 to 629 HKD per share [1] - The share buyback is part of the 2023 share option plan adopted on May 17, 2023, with 11,800 shares issued through the exercise of share options on November 26, 2025 [1]

Core Points - Tencent Holdings (00700) announced a share buyback of 63.6 million HKD for 1.022 million shares at a price range of 618.5 to 629 HKD per share [1] - The share buyback is scheduled for November 26, 2025, and is part of the stock option plan adopted on May 17, 2023 [1] - Additionally, 11,800 shares will be issued through the exercise of stock options on the same date [1]

Group 1 - Tencent Holdings announced a share buyback plan, spending HKD 636 million to repurchase 1.022 million shares [1] - The buyback price per share ranged from HKD 618.5 to HKD 629 [1]

如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 00700 | 說明 | | | | | | | | 多櫃檯證券代號 | 80700 | RMB 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行 ...